Evaluation of Microbial Colonisation and Contamination Caused by the Transvaginal and Transabdominal Access for Cholecystectomy
NCT ID: NCT01078025
Last Updated: 2010-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2010-02-28
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this cohort study is to evaluate the microbial colonisation and contamination in patients with transvaginal hybrid and conventional laparoscopic cholecystectomy.
Therefore, pre- and intraoperative microbiological evaluations will be performed in patients with transvaginal hybrid cholecystectomy and laparoscopic cholecystectomy.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transvaginal hybrid cholecystectomy
Smear test vaginally, intraabdominally
Pre- and intraoperative smear tests of the vagina and douglas are performed.
laparoscopic cholecystectomy
Smear test vaginally, intraabdominally
Pre- and intraoperative smear tests of the vagina and douglas are performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smear test vaginally, intraabdominally
Pre- and intraoperative smear tests of the vagina and douglas are performed.
Smear test vaginally, intraabdominally
Pre- and intraoperative smear tests of the vagina and douglas are performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent for laparoscopic cholecystectomy or transvaginal hybrid cholecystectomy
Exclusion Criteria
* intraabdominal infection
* existing antibiotic therapy
* adnexitis
* pelvic inflammatory disease
* infection (CRP \> 10 mg /l; Lc \> 11 G/l)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cantonal Hospital of St. Gallen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cantonal Hospital St.Gallen, Departement of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Zerz, MD
Role: PRINCIPAL_INVESTIGATOR
Cantonal Hospital St. Gallen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery
Sankt Gallen, St.Gallen, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKSG09/150/1B
Identifier Type: -
Identifier Source: org_study_id